Understanding cancer drug resistance by developing and studying resistant cell line models
Article (Published version)
© 2016 Bentham Science Publishers
MetadataShow full item record
Despite the enormous number of anticancer drugs presently available in the clinic, treatment failure due to drug resistance is very frequent. The identification of mechanisms of resistance to different drugs is necessary, in order to identify ways to prevent and circumvent such resistance. Indeed, the identification of novel therapeutic targets to overcome cancer drug resistance remains one of the major challenges in drug discovery and development. The methods employed to identify drug resistance mechanisms and novel therapeutic targets depend greatly on the establishment of cancer drug resistant cell lines. The establishment of such drug resistant cell lines is laborious and time-consuming and various different approaches have been described. This manuscript reviews the methodologies that have been used to create cancer drug resistant cell lines and to identify their mechanisms of resistance. In addition, this review highlights the most frequent drug resistance mechanisms found in cancer cells.
Keywords:Acquired drug resistance; Anticancer drugs; Cancer drug resistance; Drug resistant cancer cell lines; Isogenic cell lines; Mechanisms of drug resistance; Multidrug resistance
Source:Current Cancer Drug Targets, 2016, 16, 3, 226-237
Showing items related by title, author, creator and subject.
Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance. Podolski-Renić, Ana; Dinić, Jelena; Stanković, Tijana; Jovanović, Mirna; Ramović, Amra; Pustenko, Aleksandrs; Žalubovskis, Raivis; Pešić, Milica (European Journal of Pharmaceutical Sciences, 2019)
Uspostavljanje rezistentnih tumorskih ćelijskih linija kao modela za testiranje novih hemioterapeutika: molekularna karakterizacija rezistencije nastale dugotrajnim izlaganjem paklitakselu / The establishing of resistant cancer cell lines as a model for testing of new chemotherapeutics: molecular characterization of resistance developed after continuous treatment with paclitaxel Podolski-Renić, Ana (Belgrade: University of Belgrade, Faculty of Belgrade, 2013)
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance McCubrey, James A; Steelman, Linda S; Chappell, William H; Abrams, Stephen L; Franklin, Richard A; Montalto, Giuseppe; Cervello, Melchiorre; Libra, Massimo; Candido, Saverio; Malaponte, Graziella; Mazzarino, Maria C; Fagone, Paolo; Nicoletti, Ferdinando; Baesecke, Joerg; Mijatović, Sanja; Maksimović-Ivanić, Danijela; Milella, Michele; Tafuri, Agostino; Chiarini, Francesca; Evangelisti, Camilla; Cocco, Lucio; Martelli, Alberto M (Oncotarget, 2012)